- Report
- October 2025
- 160 Pages
Global
From €2835EUR$3,160USD£2,422GBP
€3544EUR$3,950USD£3,027GBP
- Report
- February 2026
- 188 Pages
Global
From €4351EUR$4,850USD£3,717GBP
- Report
- February 2026
- 195 Pages
Global
From €4351EUR$4,850USD£3,717GBP
- Report
- December 2025
- 139 Pages
Global
From €4351EUR$4,850USD£3,717GBP
- Report
- October 2025
- 160 Pages
Global
From €4351EUR$4,850USD£3,717GBP
- Report
- August 2025
- 194 Pages
Global
From €3181EUR$3,545USD£2,717GBP
€3534EUR$3,939USD£3,019GBP
- Report
- August 2025
- 196 Pages
Global
From €3181EUR$3,545USD£2,717GBP
€3534EUR$3,939USD£3,019GBP
- Report
- August 2025
- 182 Pages
Global
From €3181EUR$3,545USD£2,717GBP
€3534EUR$3,939USD£3,019GBP
- Report
- August 2025
- 181 Pages
Global
From €3181EUR$3,545USD£2,717GBP
€3534EUR$3,939USD£3,019GBP
- Report
- July 2025
- 200 Pages
Japan
From €2234EUR$2,490USD£1,908GBP
- Report
- August 2022
- 120 Pages
Global
From €4037EUR$4,500USD£3,449GBP
- Report
- August 2025
- 185 Pages
Global
From €3181EUR$3,545USD£2,717GBP
€3534EUR$3,939USD£3,019GBP
- Report
- September 2024
- 82 Pages
Japan
From €3140EUR$3,500USD£2,682GBP
- Report
- October 2023
- 84 Pages
Canada
From €3140EUR$3,500USD£2,682GBP
- Report
- October 2023
- 89 Pages
Egypt
From €3140EUR$3,500USD£2,682GBP
- Report
- August 2023
- 75 Pages
Israel
From €3140EUR$3,500USD£2,682GBP
- Report
- September 2023
- 83 Pages
Israel
From €3140EUR$3,500USD£2,682GBP
- Clinical Trials
- April 2025
- 240 Pages
Global
From €2243EUR$2,500USD£1,916GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1346EUR$1,500USD£1,150GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1346EUR$1,500USD£1,150GBP

The Vasodilator market is a segment of the Medical Devices industry that focuses on the development and sale of products used to widen blood vessels. These products are used to treat a variety of conditions, including hypertension, coronary artery disease, and peripheral vascular disease. Vasodilators are typically administered through injection, infusion, or inhalation, and can be used to reduce blood pressure, improve blood flow, and reduce the risk of stroke and heart attack.
The Vasodilator market is highly competitive, with a number of large and small companies offering a variety of products. Major players in the market include Pfizer, Merck, Novartis, and Sanofi, while smaller companies such as Bausch Health, Mylan, and Teva Pharmaceuticals also offer products. Additionally, many generic drug manufacturers produce generic versions of popular vasodilators. Show Less Read more